| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 417 |
| 1 | FUROSEMIDE | 411 |
| 2 | ASPIRIN 325 MG | 396 |
| 3 | ASPIRIN 81 MG | 396 |
| 4 | APIXABAN | 365 |
| 5 | METOPROLOL TARTRATE | 271 |
| 6 | BOSENTAN | 240 |
| 7 | RIVAROXABAN | 239 |
| 8 | METOPROLOL | 234 |
| 9 | AMBRISENTAN | 225 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PATISIRAN | 41 | 0.0145 |
| 1 | RANOLAZINE | 116 | 0.0110 |
| 2 | TAFAMIDIS | 83 | 0.0068 |
| 3 | ERGOCALCIFEROL | 186 | 0.0063 |
| 4 | APIXABAN | 365 | 0.0054 |
| 5 | BOSENTAN | 240 | 0.0048 |
| 6 | DOFETILIDE | 50 | 0.0048 |
| 7 | SOTALOL HYDROCHLORIDE | 50 | 0.0030 |
| 8 | MACITENTAN | 168 | 0.0024 |
| 9 | DIGOXIN | 171 | 0.0024 |
| # | Drug class | Count |
|---|---|---|
| 0 | Factor Xa Inhibitor [EPC] | 600 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 563 |
| 2 | Loop Diuretic [EPC] | 485 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 422 |
| 4 | Endothelin Receptor Antagonist [EPC] | 393 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 280 |
| 6 | beta-Adrenergic Blocker [EPC] | 278 |
| 7 | Corticosteroid [EPC] | 263 |
| 8 | Insulin Analog [EPC] | 254 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 232 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 36 | 0.0523 |
| 1 | Anti-anginal [EPC] | 116 | 0.0110 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 17 | 0.0082 |
| 3 | Provitamin D2 Compound [EPC] | 186 | 0.0063 |
| 4 | Sucrose-specific Enzyme [EPC] | 1 | 0.0055 |
| 5 | PCSK9 Inhibitor [EPC] | 93 | 0.0036 |
| 6 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 34 | 0.0035 |
| 7 | Complement Factor D Inhibitor [EPC] | 1 | 0.0032 |
| 8 | Neonatal Fc Receptor Blocker [EPC] | 13 | 0.0030 |
| 9 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |